Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
O. Kuchel. (1989) The Heterogeneity of Dopamine Involvement in Essential Hypertension. Clinical and Experimental Hypertension. Part A: Theory and Practice 11:sup1, pages 217-225.
Read now
Read now
A.G. Dupont. (1988) Dopamine Receptors And Hypertension. Acta Clinica Belgica 43:1, pages 1-7.
Read now
Read now
Articles from other publishers (14)
Rajan Giri, Ian Alberts & Wayne W. Harding. (2020)
Synthesis, pharmacological evaluations, and molecular docking studies on a new 1,3,4,11b‐tetrahydro‐1
H
‐fluoreno[9,1‐
cd
]azepine framework: Rigidification of D
1
receptor selective 1‐phenylbenzazepines and discovery of a new 5‐HT
6
receptor scaffold
. Chemical Biology & Drug Design 96:2, pages 825-835.
Crossref
Crossref
Albertino Damasceno, Alejandro Santos, Paula Serrão, Paula Caupers, Patrício Soares-da-Silva & Jorge Polónia. (1999) Deficiency of renal dopaminergic-dependent natriuretic response to acute sodium load in black salt-sensitive subjects in contrast to salt-resistant subjects. Journal of Hypertension 17:Supplement, pages 1995-2001.
Crossref
Crossref
Gordon S. Stokes, Judith C. Monaghan & Dilo N. Pillai. (1997) Effects of carbidopa and of intravenous saline infusion into normal and hypertensive subjects on urinary free and conjugated dopamine. Journal of Hypertension 15:7, pages 761-768.
Crossref
Crossref
Murray David Esler. (1993) Catecholamines and essential hypertension. Baillière's Clinical Endocrinology and Metabolism 7:2, pages 415-438.
Crossref
Crossref
Nicholas G. Moss, Romulo E. Colindres & Carl W. Gottschalk. 2011. Comprehensive Physiology. Comprehensive Physiology
1061
1128
.
Michael J. Parnham, Erich Graf, Vera M. Kolb, Renu Seth, Shradha Sinha, Robert R. RuffoloJr.Jr., J. Paul Hieble, David P. Brooks, Giora Z. Feuerstein, Andrew J. Nichols & P. G. De BenedettiRobert R. RuffoloJrJr, J. Paul Hieble, David P. Brooks, Giora Z. Feuerstein & Andrew J. Nichols. 1991. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques
117
360
.
Henk H. W. Thijssen & Hans C. Drieman. (2007) Prodrugs in Cardiovascular Medicine. Cardiovascular Drug Reviews 8:4, pages 386-400.
Crossref
Crossref
Ralph DawsonJr.Jr. & M. Ian Phillips. (1990) Dopamine synthesis and release in LLC-PK1 cells. European Journal of Pharmacology: Molecular Pharmacology 189:6, pages 423-426.
Crossref
Crossref
N. Sunn, P.J. Harris & C. Bell. (1990) Effects on renal sympathetic axons in dog of acute 6-hydroxydopamine treatment in combination with selective neuronal uptake inhibitors. British Journal of Pharmacology 99:4, pages 655-660.
Crossref
Crossref
JP Hieble, RJ Eden & C. de Mey. (2012) The role of DA1‐ and DA2‐receptors in the control of blood pressure.. British Journal of Clinical Pharmacology 30:S1.
Crossref
Crossref
Isabelle Gregoire, Najeh El Esper, Jean Gondry, Francis Boitte, Patrick Fievet, Rafat Makdassi, Pierre François Westeel, Jean Daniel Lalau, Hervé Favre, A. de Bold & Albert Fournier. (1990) Plasma atrial natriuretic factor and urinary excretion of a ouabain displacing factor and dopamine in normotensive pregnant women before and after delivery. American Journal of Obstetrics and Gynecology 162:1, pages 71-76.
Crossref
Crossref
Charles B. Hathaway & August Epple. (1989) The sources of plasma catecholamines in the American eel, Anguilla rostrata. General and Comparative Endocrinology 74:3, pages 418-430.
Crossref
Crossref
Christopher Bell. (1989) Peripheral dopaminergic nerves. Pharmacology & Therapeutics 44:2, pages 157-179.
Crossref
Crossref
T. Petrovic, P.J. Harris & C. Bell. (1988) Comparison of resting and stimulus-evoked catecholamine release from the femoral and renal vascular beds of the dog. Journal of the Autonomic Nervous System 25:2-3, pages 195-203.
Crossref
Crossref